Literature DB >> 20010787

Proteasomes in immune cells: more than peptide producers?

Marcus Groettrup1, Christopher J Kirk, Michael Basler.   

Abstract

When cells are stimulated with pro-inflammatory cytokines, most of their constitutively expressed proteasomes are replaced with immunoproteasomes, which increase the production of peptides for presentation on MHC class I molecules. In addition, cortical thymic epithelial cells selectively express a type of proteasome known as the thymoproteasome that is required for the positive selection of thymocytes. Here, we discuss how these specialized types of proteasome shape the T cell receptor repertoire of cytotoxic T lymphocytes and propose that immunoproteasomes have functions, in addition to antigen processing, that influence cytokine production and T cell differentiation, survival and function. We also discuss how inhibitors of immunoproteasomes can suppress undesired T cell responses in autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20010787     DOI: 10.1038/nri2687

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  59 in total

Review 1.  Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens.

Authors:  William R Heath; Gabrielle T Belz; Georg M N Behrens; Christopher M Smith; Simon P Forehan; Ian A Parish; Gayle M Davey; Nicholas S Wilson; Francis R Carbone; Jose A Villadangos
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

2.  Immunoproteasome subunit deficiencies impact differentially on two immunodominant influenza virus-specific CD8+ T cell responses.

Authors:  Ken C Pang; Megan T Sanders; John J Monaco; Peter C Doherty; Stephen J Turner; Weisan Chen
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

3.  Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands.

Authors:  T P Dick; T Ruppert; M Groettrup; P M Kloetzel; L Kuehn; U H Koszinowski; S Stevanović; H Schild; H G Rammensee
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

4.  Proteasome from Thermoplasma acidophilum: a threonine protease.

Authors:  E Seemüller; A Lupas; D Stock; J Löwe; R Huber; W Baumeister
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

5.  MHC-linked LMP gene products specifically alter peptidase activities of the proteasome.

Authors:  J Driscoll; M G Brown; D Finley; J J Monaco
Journal:  Nature       Date:  1993-09-16       Impact factor: 49.962

Review 6.  Structural plasticity of the proteasome and its function in antigen processing.

Authors:  M Groettrup; M van den Broek; K Schwarz; A Macagno; S Khan; R de Giuli; G Schmidtke
Journal:  Crit Rev Immunol       Date:  2001       Impact factor: 2.214

7.  Interferon-gamma induces different subunit organizations and functional diversity of proteasomes.

Authors:  M Aki; N Shimbara; M Takashina; K Akiyama; S Kagawa; T Tamura; N Tanahashi; T Yoshimura; K Tanaka; A Ichihara
Journal:  J Biochem       Date:  1994-02       Impact factor: 3.387

8.  Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

Authors:  P S Ohashi; S Oehen; K Buerki; H Pircher; C T Ohashi; B Odermatt; B Malissen; R M Zinkernagel; H Hengartner
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

Review 9.  Recognition and processing of ubiquitin-protein conjugates by the proteasome.

Authors:  Daniel Finley
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

10.  Incorporation of major histocompatibility complex--encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-gamma.

Authors:  U Kuckelkorn; S Frentzel; R Kraft; S Kostka; M Groettrup; P M Kloetzel
Journal:  Eur J Immunol       Date:  1995-09       Impact factor: 5.532

View more
  113 in total

Review 1.  Aging and immune function: molecular mechanisms to interventions.

Authors:  Subramaniam Ponnappan; Usha Ponnappan
Journal:  Antioxid Redox Signal       Date:  2011-01-08       Impact factor: 8.401

2.  Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules.

Authors:  Danielle de Verteuil; Tara L Muratore-Schroeder; Diana P Granados; Marie-Hélène Fortier; Marie-Pierre Hardy; Alexandre Bramoullé; Etienne Caron; Krystel Vincent; Sylvie Mader; Sébastien Lemieux; Pierre Thibault; Claude Perreault
Journal:  Mol Cell Proteomics       Date:  2010-05-19       Impact factor: 5.911

Review 3.  Immunoproteasomes: structure, function, and antigen presentation.

Authors:  Deborah A Ferrington; Dale S Gregerson
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

4.  Loss of recognition by cross-reactive T cells and its relation to a C-terminus-induced conformational reorientation of an HLA-B*2705-bound peptide.

Authors:  Bernhard Loll; Christine Rückert; Chee Seng Hee; Wolfram Saenger; Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  Protein Sci       Date:  2010-12-23       Impact factor: 6.725

Review 5.  Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands.

Authors:  Gabor Mester; Vanessa Hoffmann; Stefan Stevanović
Journal:  Cell Mol Life Sci       Date:  2011-03-09       Impact factor: 9.261

6.  A humanized yeast proteasome identifies unique binding modes of inhibitors for the immunosubunit β5i.

Authors:  Eva M Huber; Wolfgang Heinemeyer; Gerjan de Bruin; Herman S Overkleeft; Michael Groll
Journal:  EMBO J       Date:  2016-10-27       Impact factor: 11.598

7.  Emerging Cancer Therapeutic Targets in Protein Homeostasis.

Authors:  Prabhakar Bastola; Derek B Oien; Megan Cooley; Jeremy Chien
Journal:  AAPS J       Date:  2018-08-27       Impact factor: 4.009

8.  Activity-based near-infrared fluorescent probe for LMP7: a chemical proteomics tool for the immunoproteasome in living cells.

Authors:  Lalit Kumar Sharma; Na-Ra Lee; Eun Ryoung Jang; Beilei Lei; Chang-Guo Zhan; Wooin Lee; Kyung-Bo Kim
Journal:  Chembiochem       Date:  2012-07-17       Impact factor: 3.164

9.  Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit.

Authors:  Henry W B Johnson; Janet L Anderl; Erin K Bradley; John Bui; Jeffrey Jones; Shirin Arastu-Kapur; Lisa M Kelly; Eric Lowe; David C Moebius; Tony Muchamuel; Christopher Kirk; Zhengping Wang; Dustin McMinn
Journal:  ACS Med Chem Lett       Date:  2017-03-09       Impact factor: 4.345

Review 10.  Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy.

Authors:  Michael Basler; Marcus Groettrup
Journal:  Genes Immun       Date:  2020-08-25       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.